"Pathway","Total","Expected","Hits","P.Value","FDR"
"Immune System",1140,511,731,5.01e-47,7.03e-44
"Adaptive Immune System",654,294,440,6.37e-34,4.47e-31
"Cell Cycle, Mitotic",411,185,298,1.33e-31,6.22e-29
"Cell Cycle",508,228,352,7.97e-31,2.79e-28
"Cytokine Signaling in Immune system",286,128,211,4.37e-24,1.22e-21
"Apoptosis",158,71,131,2.35e-23,5.04e-21
"S Phase",122,54.8,107,2.51e-23,5.04e-21
"mRNA Processing",140,62.9,119,3.29e-23,5.76e-21
"Processing of Capped Intron-Containing Pre-mRNA",119,53.4,104,1.97e-22,3.07e-20
"Mitotic G1-G1/S phases",140,62.9,118,2.28e-22,3.19e-20
"Mitotic M-M/G1 phases",266,119,196,2.58e-22,3.28e-20
"mRNA Splicing",115,51.7,101,3.51e-22,3.79e-20
"mRNA Splicing - Major Pathway",115,51.7,101,3.51e-22,3.79e-20
"HIV Infection",214,96.1,164,7.52e-22,7.53e-20
"Class I MHC mediated antigen processing & presentation",267,120,194,6.7e-21,6.26e-19
"Developmental Biology",417,187,279,8.07e-21,7.07e-19
"Signalling by NGF",290,130,204,3.33e-19,2.75e-17
"Antigen processing: Ubiquitination & Proteasome degradation",224,101,165,6.63e-19,5.16e-17
"Synthesis of DNA",95,42.7,83,4.14e-18,3.06e-16
"G1/S Transition",113,50.8,95,4.52e-18,3.17e-16
"M Phase",233,105,168,1.13e-17,7.53e-16
"DNA Replication",102,45.8,87,1.8e-17,1.15e-15
"Signaling by TGF-beta Receptor Complex",70,31.4,64,1.63e-16,9.93e-15
"Removal of licensing factors from origins",71,31.9,64,9.3e-16,5.22e-14
"Regulation of DNA replication",71,31.9,64,9.3e-16,5.22e-14
"Signaling by the B Cell Receptor (BCR)",199,89.4,144,1.6e-15,8.63e-14
"Cell Cycle Checkpoints",131,58.8,103,1.74e-15,9.02e-14
"Hemostasis",511,230,315,2.06e-15,1.03e-13
"Regulation of mRNA Stability by Proteins that Bind AU-rich Elements",88,39.5,75,3.47e-15,1.68e-13
"Switching of origins to a post-replicative state",69,31,62,3.83e-15,1.73e-13
"Orc1 removal from chromatin",69,31,62,3.83e-15,1.73e-13
"Signaling by Interleukins",116,52.1,93,4.41e-15,1.93e-13
"Host Interactions of HIV factors",141,63.3,108,9.66e-15,4.1e-13
"TRIF-mediated TLR3/TLR4 signaling ",87,39.1,73,4.49e-14,1.85e-12
"Mitotic Metaphase and Anaphase",199,89.4,141,5.33e-14,2.13e-12
"Degradation of beta-catenin by the destruction complex",65,29.2,58,6.37e-14,2.41e-12
"Signaling by Wnt",65,29.2,58,6.37e-14,2.41e-12
"Mitotic Anaphase",198,88.9,140,8.58e-14,3.17e-12
"DNA Replication Pre-Initiation",80,35.9,68,9.23e-14,3.24e-12
"M/G1 Transition",80,35.9,68,9.23e-14,3.24e-12
"Transcription",149,66.9,111,1.17e-13,4.01e-12
"MyD88-independent cascade ",88,39.5,73,1.48e-13,4.77e-12
"Toll Like Receptor 3 (TLR3) Cascade",88,39.5,73,1.48e-13,4.77e-12
"Downstream Signaling Events Of B Cell Receptor (BCR)",173,77.7,125,1.5e-13,4.77e-12
"Assembly of the pre-replicative complex",63,28.3,56,2.56e-13,7.99e-12
"Cyclin A:Cdk2-associated events at S phase entry",66,29.6,58,2.96e-13,9.02e-12
"NGF signalling via TRKA from the plasma membrane",207,93,144,3.06e-13,9.14e-12
"Toll Like Receptor 4 (TLR4) Cascade",103,46.3,82,3.96e-13,1.16e-11
"Axon guidance",292,131,191,4.63e-13,1.32e-11
"Interferon Signaling",173,77.7,124,4.88e-13,1.37e-11
"Activated TLR4 signalling",100,44.9,79,2.29e-12,6.3e-11
"APC/C-mediated degradation of cell cycle proteins",89,40,72,2.54e-12,6.71e-11
"Regulation of mitotic cell cycle",89,40,72,2.54e-12,6.71e-11
"Separation of Sister Chromatids",186,83.5,130,2.65e-12,6.87e-11
"Platelet activation, signaling and aggregation",220,98.8,149,3.42e-12,8.71e-11
"RNA Polymerase II Transcription",107,48.1,83,3.84e-12,9.62e-11
"Cyclin E associated events during G1/S transition ",65,29.2,56,4.71e-12,1.16e-10
"Disease",945,424,521,6.85e-12,1.66e-10
"Signaling by EGFR in Cancer",181,81.3,126,9.04e-12,2.15e-10
"Regulation of APC/C activators between G1/S and early anaphase",84,37.7,68,9.85e-12,2.3e-10
"Signaling by SCF-KIT",142,63.8,103,1.49e-11,3.41e-10
"Fcgamma receptor (FCGR) dependent phagocytosis",86,38.6,69,1.53e-11,3.46e-10
"CDT1 association with the CDC6:ORC:origin complex",57,25.6,50,1.59e-11,3.54e-10
"Antiviral mechanism by IFN-stimulated genes",69,31,58,1.68e-11,3.63e-10
"ISG15 antiviral mechanism",69,31,58,1.68e-11,3.63e-10
"Activation of NF-kappaB in B Cells",66,29.6,56,1.75e-11,3.72e-10
"Signaling by EGFR",179,80.4,124,2.25e-11,4.71e-10
"Transcriptional Regulation of White Adipocyte Differentiation",56,25.2,49,3.14e-11,6.48e-10
"TRAF6 Mediated Induction of proinflammatory cytokines",62,27.8,53,3.41e-11,6.93e-10
"Late Phase of HIV Life Cycle",108,48.5,82,3.8e-11,7.6e-10
"Membrane Trafficking",203,91.2,137,3.88e-11,7.66e-10
"SCF(Skp2)-mediated degradation of p27/p21",58,26.1,50,6.52e-11,1.27e-09
"Signaling by FGFR in disease",178,79.9,122,9.94e-11,1.91e-09
"Innate Immune System",521,234,304,1.03e-10,1.95e-09
"HIV Life Cycle",128,57.5,93,1.27e-10,2.37e-09
"Metabolism of RNA",339,152,209,1.58e-10,2.91e-09
"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1",76,34.1,61,2.31e-10,4.21e-09
"SCF-beta-TrCP mediated degradation of Emi1",53,23.8,46,2.38e-10,4.27e-09
"Regulation of Apoptosis",59,26.5,50,2.41e-10,4.28e-09
"L1CAM interactions",112,50.3,83,2.45e-10,4.3e-09
"MyD88:Mal cascade initiated on plasma membrane",81,36.4,64,2.89e-10,4.83e-09
"Toll Like Receptor TLR1:TLR2 Cascade",81,36.4,64,2.89e-10,4.83e-09
"Toll Like Receptor TLR6:TLR2 Cascade",81,36.4,64,2.89e-10,4.83e-09
"Toll Like Receptor 2 (TLR2) Cascade",81,36.4,64,2.89e-10,4.83e-09
"Signaling by ERBB4",152,68.3,106,3.56e-10,5.87e-09
"Toll-Like Receptors Cascades",123,55.2,89,4.56e-10,7.44e-09
"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins",77,34.6,61,6.27e-10,9.87e-09
"Toll Like Receptor 7/8 (TLR7/8) Cascade",77,34.6,61,6.27e-10,9.87e-09
"MyD88 dependent cascade initiated on endosome",77,34.6,61,6.27e-10,9.87e-09
"Destabilization of mRNA by AUF1 (hnRNP D0)",54,24.3,46,9.07e-10,1.41e-08
"Toll Like Receptor 9 (TLR9) Cascade",79,35.5,62,9.16e-10,1.41e-08
"Autodegradation of Cdh1 by Cdh1:APC/C",68,30.5,55,1.05e-09,1.6e-08
"Cdc20:Phospho-APC/C mediated degradation of Cyclin A",76,34.1,60,1.12e-09,1.65e-08
"APC/C:Cdc20 mediated degradation of mitotic proteins",76,34.1,60,1.12e-09,1.65e-08
"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",76,34.1,60,1.12e-09,1.65e-08
"Downstream signal transduction",163,73.2,111,1.28e-09,1.87e-08
"G1/S DNA Damage Checkpoints",62,27.8,51,1.38e-09,1.97e-08
"Regulation of actin dynamics for phagocytic cup formation",62,27.8,51,1.38e-09,1.97e-08
"Recycling pathway of L1",44,19.8,39,1.52e-09,2.15e-08
"Vpu mediated degradation of CD4",50,22.5,43,1.75e-09,2.46e-08
"Intrinsic Pathway for Apoptosis",37,16.6,34,1.94e-09,2.69e-08
"DNA Repair",117,52.6,84,2.66e-09,3.65e-08
"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer",43,19.3,38,3.03e-09,4.12e-08
"MAP kinase activation in TLR cascade",55,24.7,46,3.13e-09,4.22e-08
"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A",52,23.4,44,3.32e-09,4.28e-08
"p53-Independent DNA Damage Response",52,23.4,44,3.32e-09,4.28e-08
"p53-Independent G1/S DNA damage checkpoint",52,23.4,44,3.32e-09,4.28e-08
"Ubiquitin-dependent degradation of Cyclin D1",49,22,42,3.39e-09,4.28e-08
"CDK-mediated phosphorylation and removal of Cdc6",49,22,42,3.39e-09,4.28e-08
"Ubiquitin-dependent degradation of Cyclin D",49,22,42,3.39e-09,4.28e-08
"Regulation of ornithine decarboxylase (ODC)",49,22,42,3.39e-09,4.28e-08
"Toll Like Receptor 10 (TLR10) Cascade",74,33.2,58,3.54e-09,4.35e-08
"Toll Like Receptor 5 (TLR5) Cascade",74,33.2,58,3.54e-09,4.35e-08
"MyD88 cascade initiated on plasma membrane",74,33.2,58,3.54e-09,4.35e-08
"ER-Phagosome pathway",63,28.3,51,4.09e-09,4.99e-08
"Cytosolic tRNA aminoacylation",24,10.8,24,4.32e-09,5.19e-08
"APC/C:Cdc20 mediated degradation of Securin",71,31.9,56,4.33e-09,5.19e-08
"Signaling by ERBB2",164,73.7,110,5.86e-09,6.96e-08
"Chaperonin-mediated protein folding",51,22.9,43,6.32e-09,7.44e-08
"mRNA Splicing - Minor Pathway",45,20.2,39,6.46e-09,7.54e-08
